Generex has Funding, Covad/19 Chinese Contract, Royalties, Recent Articles and WHO Recognition. The CHINESE SIGN A CONTRACT with GENEREX THIS IS HUGE when you sit back and realize the only thing holding this back is "what you tell me" This company is being looked at as an OTC Shell LOL. Its a lot more than people realize with many subs. This shell will burst onto the NASDAQ Times 2 Leading with NGIO. Fact: Covid/19 plays have been runners in recent days. You know what else I hope Generex can lead the way to make an effective vaccine. This is some serious sh"t.
LOOKS SOLID for NGIO: Our subsidiary NuGenerex Immuno-Oncology (NGIO) "Future NASDAQ Listing" has developed Ii-Key peptide vaccines against several potentially pandemic viruses, including bird flu, swine, flu, HIV, and a previous coronavirus, SARS. This wealth of experience has enabled us to develop a standardized protocol for rapid vaccine development, so we are positioned to respond in the event of a new, emerging pathogen. Our partners in China have recognized the power of our Ii-Key platform and have delivered this contract to establish a collaboration to combat the COVID-19 epidemic, and we are excited to begin the work.”
